Strategy Asset Managers LLC West Pharmaceutical Services Inc Transaction History

Strategy Asset Managers LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$338.27 - $413.0 $551,380 - $673,190	1,630 New	1,630 $645,000
Q2 2022 Jul 13, 2022	SELL	$280.61 - $420.45 $163,034 - $244,281	-581 Closed	0 $0
Q1 2022 Apr 11, 2022	SELL	$357.49 - $445.92 $483,326 - $602,883	-1,352 Reduced 69.94%	581 $239,000
Q4 2021 Jan 14, 2022	SELL	$402.25 - $471.34 $325,822 - $381,785	-810 Reduced 29.53%	1,933 $907,000
Q3 2021 Dec 14, 2021	BUY	$363.01 - $468.47 $260,278 - $335,892	717 Added 35.39%	2,743 $1.17 Million
Q2 2021 Aug 04, 2021	SELL	$284.77 - $363.2 $69,199 - $88,257	-243 Reduced 10.71%	2,026 $728,000
Q1 2021 May 12, 2021	BUY	$257.29 - $307.53 $583,791 - $697,785	2,269 New	2,269 $639,000

803

64.4M

294K

490K

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $24.7B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

Get notified when there are updates to the investment portfolio of Strategy Asset Managers LLC, based on Form 13F filings with the SEC.

Stay updated on Strategy Asset Managers LLC with notifications on news.